Resources

Topic

All Analytics Antibody-drug conjugates Bioanalytics Biologics Biosimilars Biostatistics Cancer Cell culture Clinical trials Contamination Drug development Drug product Drug substance EMA FDA GMP Mabion Manufacturing Microbiology Partnership Proteins Regulatory Vaccines Veterinary biologics

Type

All Poster

quantitation of monoclonal antibodies in serum - new technologies ECL, Gyrolab, and LC-MS/MS vs gold standard ELISA

Quantitation of monoclonal antibodies in serum: new technologies ECL, Gyrolab, and LC-MS/MS vs gold standard ELISA

Immunogenicity Impact on Efficacy and Safety of Biosimilars

Impact of immunogenicity on efficacy and safety of biosimilars – importance of ADA and nAb testing during the clinical development

Biologics, Drug product

Mycoplasma Contamination Risks in Biomanufacturing

Mycoplasma contamination in biopharmaceutical manufacturing

Biologics, Cell culture, Contamination, Manufacturing

Glycosylation's Impact on Antibody Effector Functions

Impact of glycosylation on the effector functions of monoclonal antibodies: a case study of rituximab

Bioanalytics, Biologics, Drug substance, Manufacturing

Previous 1 … 11 12